Lv41
498 积分 2024-04-17 加入
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
3小时前
待确认
Rapid manufacturing of CAR-T therapy: strategies and impact
4个月前
已完结
CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges
4个月前
已完结
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial
5个月前
已完结
Accelerating and optimising CAR T-cell manufacture to deliver better patient products
7个月前
已完结
Emerging Advances in Nano-biomaterial Assisted Amyloid Beta Chimeric Antigen Receptor Macrophages (CAR-M) Therapy: Reducing Plaque Burden in Alzheimer's Disease
11个月前
已完结
A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects
1年前
已完结
Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer
1年前
已完结
A CAR enhancer increases the activity and persistence of CAR T cells
1年前
已完结
CAR T cell combination therapies to treat cancer
1年前
已完结
皖公网安备34019202002308
